The use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers may relate to the survival and walking ability in geriatric patients with hip fractures: a 1-year follow-up study

Table 4 Logistics analysis of mortalities and free walking abilities at 3 months, 6 months, and 1 year

Variables	3-month mortality		6-month mortality		1-year mortality
Variables	OR (95% CI)	p value	OR (95% CI)	p value	OR (95% CI)	p value
non-users with hypertension (Ref)
non-users without hypertension	0.575 (0.212—1.748)	0.297	0.470 (0.226—1.006)	0.046	0.259 (0.136—0.486)	< 0.001
ACEI users	0.260 (0.069—0.937)	0.038	0.235 (0.096—0.563)	0.001	0.112 (0.053—0.227)	< 0.001
ARB users	0.317 (0.062—1.333)	0.13	0.292 (0.101—0.779)	0.017	0.154 (0.067—0.338)	< 0.001
Variables	3-month free walking ability		6-month free walking ability		1-year free walking ability
Variables	OR (95% CI)	p value	OR (95% CI)	p value	OR (95% CI)	p value
non-users with hypertension (Ref)
non-users without hypertension	1.072 (0.655—1.793)	0.785	1.853 (1.192—2.912)	0.007	4.212 (2.577—6.987)	< 0.001
ACEI users	1.041 (0.597—1.841)	0.888	5.808 (3.493—9.807)	< 0.001	13.205 (7.287—24.587)	< 0.001
ARB users	1.102 (0.610—1.999)	0.748	5.393 (3.133—9.456)	< 0.001	10.156 (5.327—20.121)	< 0.001

ISSN: 1471-2474